How a new precision technique could help oncologists pick which drugs to give patients

New study suggests there are approved medicines available to cancer patients right now that might save their lives — if only clinicians were able to see which ones.

April 12, 2024 Check out STAT+

Sponsored By

Scott McIntyre for STAT STAT+ | When a cancer drug fails, oncologists often fly blind. A precision technique might light the way A study of children with cancer shows that testing tumor cells against hundreds of drugs, called functional precision medicine, can have great benefit. By Angus Chen NCI director expresses optimism about next era of cancer research, despite shrinking budget and brain drain National Cancer Institute Director Kimryn Rathmell is hopeful oncology advances and collaboration will aid Cancer Moonshot and other research. By Jonathan Wosen STAT+ | Cancer vaccines gain momentum, after years of disappointing results Data from two early-stage clinical trials hint that cancer vaccines might be used to prevent or lower the risk of relapse after surgery. By Angus Chen Adobe STAT+ | Biden administration urged to license prostate cancer drug patents in a bid to lower its cost The groups say the government has the right under federal laws to authorize "qualified companies" to make and sell generic versions of Xtandi. By Ed Silverman

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Cancer Briefing? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2024, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser